InsiderTrades

Form 4 for IDXX Idexx Laboratories

Accepted 2024-08-07 00:00:00 ET · period of report 2024-08-05 · accession 0000874716-24-000124 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-07 2024-08-05 IDXX MCKEON BRIAN P EVP, CFO, Treas M - OptEx $0.00 +192 31.0K +0.6% $0
D 2024-08-07 2024-08-05 IDXX MCKEON BRIAN P EVP, CFO, Treas F - Tax $455.08 -117 30.9K -0.4% -$53.2K
D 2024-08-07 2024-08-05 IDXX MCKEON BRIAN P EVP, CFO, Treas M - OptEx — -192 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-05 M A 192 $0.00 31,048.59 D — — (F1) (1) Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024.
2 Common Common Stock 2024-08-05 F D 117 $455.08 30,931.59 D — —
3 Derivative Restricted Stock Unit 2024-08-05 M D 192 — 0 D — · — to — 192 Common Stock (F3) Not applicable (F2) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020.